title: Digitally‐enabled, patient‐centred care in rhinitis and asthma multimorbidity: The ARIA‐MASK‐air® approach
Creators: name: Bousquet, Jean
name: Anto, Josep M.
name: Sousa‐Pinto, Bernardo
name: Czarlewski, Wienczyslawa
name: Bedbrook, Anna
name: Haahtela, Tari
name: Klimek, Ludger
name: Pfaar, Oliver
name: Kuna, Piotr
name: Kupczyk, Maciej
name: Regateiro, Frederico S.
name: Samolinski, Boleslaw
name: Valiulis, Arunas
name: Yorgancioglu, Arzu
name: Arnavielhe, Sylvie
name: Basagaña, Xavier
name: Bergmann, Karl C.
name: Bosnic‐Anticevich, Sinthia
name: Brussino, Luisa
name: Canonica, G. Walter
name: Cardona, Victoria
name: Cecchi, Lorenzo
name: Chaves‐Loureiro, Claudia
name: Costa, Elisio
name: Cruz, Alvaro A.
name: Gemicioglu, Bilun
name: Fokkens, Wytske J.
name: Ivancevich, Juan Carlos
name: Kraxner, Helga
name: Kvedariene, Violeta
name: Larenas‐Linnemann, Désirée E.
name: Laune, Daniel
name: Louis, Renaud
name: Makris, Michael
name: Maurer, Marcus
name: Melén, Erik
name: Micheli, Yann
name: Morais‐Almeida, Mario
name: Mullol, Joaquim
name: Niedoszytko, Marek
name: Okamoto, Yoshitaka
name: Papadopoulos, Nikolaos G.
name: Patella, Vincenzo
name: Pham‐Thi, Nhân
name: Rouadi, Philip W.
name: Sastre, Joaquin
name: Scichilone, Nicola
name: Sheikh, Aziz
name: Sofiev, Mikhail
name: Taborda‐Barata, Luis
name: Toppila‐Salmi, Sanna
name: Tsiligianni, Ioanna
name: Valovirta, Erkka
name: Ventura, Maria Teresa
name: Vieira, Rafael José
name: Zidarn, Mihaela
name: Amaral, Rita
name: Ansotegui, Ignacio J.
name: Bédard, Annabelle
name: Benveniste, Samuel
name: Bewick, Michael
name: Bindslev‐Jensen, Carsten
name: Blain, Hubert
name: Bonini, Matteo
name: Bourret, Rodolphe
name: Braido, Fulvio
name: Carreiro‐Martins, Pedro
name: Charpin, Denis
name: Cherrez‐Ojeda, Ivan
name: Chivato, Tomas
name: Chu, Derek K.
name: Cingi, Cemal
name: Del Giacco, Stefano
name: De Blay, Frédéric
name: Devillier, Philippe
name: De Vries, Govert
name: Doulaptsi, Maria
name: Doyen, Virginie
name: Dray, Gérard
name: Fontaine, Jean‐François
name: Gomez, R. Maximiliano
name: Hagemann, Jan
name: Heffler, Enrico
name: Hofmann, Maja
name: Jassem, Ewa
name: Jutel, Marek
name: Keil, Thomas
name: Kritikos, Vicky
name: Kull, Inger
name: Kulus, Marek
name: Lourenço, Olga
name: Mathieu‐Dupas, Eve
name: Menditto, Enrica
name: Mösges, Ralph
name: Murray, Ruth
name: Nadif, Rachel
name: Neffen, Hugo
name: Nicola, Stefania
name: O’Hehir, Robyn
name: Olze, Heidi
name: Palamarchuk, Yuliia
name: Pépin, Jean‐Louis
name: Pétré, Benoit
name: Picard, Robert
name: Pitsios, Constantinos
name: Puggioni, Francesca
name: Quirce, Santiago
name: Raciborski, Filip
name: Reitsma, Sietze
name: Roche, Nicolas
name: Rodriguez‐Gonzalez, Monica
name: Romantowski, Jan
name: Sá‐Sousa, Ana
name: Serpa, Faradiba S.
name: Savouré, Marine
name: Shamji, Mohamed H.
name: Sova, Milan
name: Sperl, Annette
name: Stellato, Cristiana
name: Todo‐Bom, Ana
name: Tomazic, Peter Valentin
name: Vandenplas, Olivier
name: Van Eerd, Michiel
name: Vasankari, Tuula
name: Viart, Frédéric
name: Waserman, Susan
name: Fonseca, Joao A.
name: Zuberbier, Torsten
Publisher: name: Charité - Universitätsmedizin Berlin
Year: 2023
Subjects: subject: asthma
subject: digital
subject: MASK-air
subject: mHealth
subject: rhinitis
classificationCode: 610
subject: Medizin und Gesundheit

description: MASK-air®, a validated mHealth app (Medical Device regulation Class IIa) has enabled large observational implementation studies in over 58,000 people with allergic rhinitis and/or asthma. It can help to address unmet patient needs in rhinitis and asthma care. MASK-air® is a Good Practice of DG Sante on digitally-enabled, patient-centred care. It is also a candidate Good Practice of OECD (Organisation for Economic Co-operation and Development). MASK-air® data has enabled novel phenotype discovery and characterisation, as well as novel insights into the management of allergic rhinitis. MASK-air® data show that most rhinitis patients (i) are not adherent and do not follow guidelines, (ii) use as-needed treatment, (iii) do not take medication when they are well, (iv) increase their treatment based on symptoms and (v) do not use the recommended treatment. The data also show that control (symptoms, work productivity, educational performance) is not always improved by medications. A combined symptom-medication score (ARIA-EAACI-CSMS) has been validated for clinical practice and trials. The implications of the novel MASK-air® results should lead to change management in rhinitis and asthma.